ArticleVaccines2026
Hybrid Whole-Genome Sequencing for Genetic Stability Assessment of Infectious Laryngotracheitis Virus Vaccine Strains.
Article in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundGenetic stability of live-attenuated infectious laryngotracheitis virus (ILTV) vaccines is essential for consistent efficacy and safety; however, marker-based assessments targeting partial genes are often insufficient given the virus's large, structurally complex genome. The ILTV genome contains long internal inverted repeats (IRs) that can give rise to genomic isomers, complicating short-read assembly and accurate resolution of genome structure.
methodsTo overcome these limitations, we used a hybrid whole-genome sequencing (WGS) strategy, combining Oxford Nanopore Technologies (ONT) long reads to improve assembly contiguity with Illumina short reads for high-accuracy polishing at the single-nucleotide level. Using this approach, we generated complete de novo genome assemblies for the commercial Serva and Salsbury #146 vaccine strains.
resultsThe assemblies showed high sequence concordance with targeted regions validated by Sanger sequencing. Whole-genome analysis further enabled detection and independent validation of a structural inversion in the unique short (US) region of the Salsbury strain, consistent with herpesvirus genome isomerization. To enable phylogenetic inference despite structural variability, we performed a pangenome-based analysis to define a conserved core-genome dataset that robustly resolved vaccine-associated lineages, separating Serva- and Salsbury-derived strains.
conclusionsCollectively, these findings show that a hybrid WGS workflow can generate high-confidence genome assemblies for the specific commercial ILTV vaccine vials analyzed and can support QC-relevant detection of major structural variations. Because this study is cross-sectional (two strains; single lot/vial per strain), it cannot distinguish potential biological lot-to-lot variation from methodological differences, and a comprehensive genetic stability evaluation will require applying this workflow across defined passage levels and/or multiple production lots.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.